Comprehensive serological profiling of human populations using a synthetic human virome

George Xu(Brigham and Women's Hospital), Tomasz Kula(Brigham and Women's Hospital), Qikai Xu(Brigham and Women's Hospital), Mamie Z. Li(Brigham and Women's Hospital), Suzanne D. Vernon(Solve ME/CFS Initiative), Thumbi Ndung’u(Ragon Institute of MGH, MIT and Harvard), Kiat Ruxrungtham(Chulalongkorn University), Jorge Sánchez(Asociación Civil Impacta Salud y Educación), Christian Brander(Institució Catalana de Recerca i Estudis Avançats), Raymond T. Chung(Massachusetts General Hospital), Kevin C. O’Connor(Yale University), Bruce D. Walker(Ragon Institute of MGH, MIT and Harvard), H. Benjamin Larman(Johns Hopkins University), Stephen J. Elledge(Brigham and Women's Hospital)
Science
June 4, 2015
Cited by 501Open Access
Full Text

Abstract

The human virome plays important roles in health and immunity. However, current methods for detecting viral infections and antiviral responses have limited throughput and coverage. Here, we present VirScan, a high-throughput method to comprehensively analyze antiviral antibodies using immunoprecipitation and massively parallel DNA sequencing of a bacteriophage library displaying proteome-wide peptides from all human viruses. We assayed over 10(8) antibody-peptide interactions in 569 humans across four continents, nearly doubling the number of previously established viral epitopes. We detected antibodies to an average of 10 viral species per person and 84 species in at least two individuals. Although rates of specific virus exposure were heterogeneous across populations, antibody responses targeted strongly conserved "public epitopes" for each virus, suggesting that they may elicit highly similar antibodies. VirScan is a powerful approach for studying interactions between the virome and the immune system.


Related Papers

No related papers found

Powered by citation graph analysis